Emerson Investment Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
$400K Hold
2,670
0.08% 103
2015
Q4
$433K Hold
2,670
0.08% 97
2015
Q3
$369K Hold
2,670
0.07% 105
2015
Q2
$410K Buy
2,670
+25
+0.9% +$4K 0.08% 112
2015
Q1
$423K Hold
2,645
0.08% 114
2014
Q4
$421K Hold
2,645
0.08% 118
2014
Q3
$372K Hold
2,645
0.07% 123
2014
Q2
$313K Sell
2,645
-50
-2% -$5.79K 0.06% 132
2014
Q1
$332K Hold
2,695
0.07% 123
2013
Q4
$307K Buy
2,695
+275
+11% +$31.3K 0.06% 127
2013
Q3
$271K Hold
2,420
0.06% 125
2013
Q2
$239K Buy
+2,420
New +$251K 0.06% 127

Other funds holding AMGN

Emerson Investment Management's AMGN Position: Q1 2016 in Review

Emerson Investment Management held its Amgen (AMGN) position steady in Q1 2016 at 2,670 shares worth $400K. The position accounts for 0.08% of the portfolio, ranked #103.

Emerson Investment Management first reported a position in AMGN in Q2 2013 and has held it in 12 quarters since. The position peaked at $433K in Q4 2015. 1,435 funds tracked by Wall St. Rank hold AMGN as of Q1 2016.

  • Emerson Investment Management held 2,670 shares of Amgen worth $400K as of Q1 2016.
  • Emerson Investment Management left its Amgen share count unchanged in Q1 2016.
  • Amgen made up 0.08% of Emerson Investment Management's portfolio in Q1 2016, its #103 holding.
  • Emerson Investment Management first reported a position in Amgen in Q2 2013 and has held it in 12 quarters since.
  • Emerson Investment Management's Amgen position peaked at $433K in Q4 2015.
  • 1,435 funds tracked by Wall St. Rank held Amgen as of Q1 2016.

Based on Emerson Investment Management's 13F filing for Q1 2016, filed 9 May 2016.